晚期糖基化终末产物受体在腹腔感染脓毒症中的研究进展

生长激素在脓毒症中应用的研究进展[J] 岳超;赵允召; 医学研究生学报 2013, 08

High-mobility group box 1 (HMGB1) in childhood: from bench to bedside[J] Valeria Chirico;Antonio Lacquaniti;Vincenzo Salpietro;Caterina Munafò;Maria Pia Calabrò;Michele Buemi;Teresa Arrigo;Carmelo Salpietro European Journal of Pediatrics 2014,

Receptor for Advanced Glycation End Products and Its Involvement in Inflammatory Diseases[J] Yaw Kuang Chuah;Rusliza Basir;Herni Talib;Tung Hing Tie;Norshariza Nordin;Madhav Bhatia International Journal of Inflammation 2013,

Soluble receptor for advanced glycation end products predicts 28-day mortality in critically ill patients with sepsis[J] Helena Brodska;Karin Malickova;Jiri Valenta;Anthony Fabio;Tomas Drabek Scandinavian Journal of Clinical & Laboratory Inv 2013,

Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock; 2012[J] R. P. Dellinger;Mitchell M. Levy;Andrew Rhodes;Djillali Annane;Herwig Gerlach;Steven M. Opal;Jonathan E. Sevransky;Charles L. Sprung;Ivor S. Douglas;Roman Jaeschke;Tiffany M. Osborn;Mark E. Nunnally;Sean R. Townsend;Konrad Reinhart;Ruth M. Kleinpell;Derek C. Angus;Clifford S. Deutschman;Flavia R. Machado;Gordon D. Rubenfeld;Steven Webb;Richard J. Beale;Jean-Louis Vincent;Rui Moreno Inten

The effect of sRAGE-Fc fusion protein attenuates inflammation and decreases mortality in a murine cecal ligation and puncture model[J] Su Jin Jeong;Beom Jin Lim;Sungha Park;Donghoon Choi;Hye Won Kim;Nam Su Ku;Sang Hoon Han;Chang Oh Kim;Jun Yong Choi;Young Goo Song;June Myung Kim Inflammation Research 2012,

Ligands of the receptor for advanced glycation end products; including high-mobility group box 1; limit bacterial dissemination during Escherichia coli peritonitis[J] Marieke A. D. van Zoelen;Ahmed Achouiti;Ann-Marie Schmidt;Huan Yang;Sandrine Florquin;Kevin J. Tracey;Tom van der Poll Critical Care Medicine 2010,

High‐mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity[J] Marco E.Bianchi;Angelo A.Manfredi Immunological Reviews 2007,

S100A8 and S100A9 in inflammation and cancer[J] Christoffer Gebhardt;Julia Németh;Peter Angel;Jochen Hess Biochemical Pharmacology 2006,

生长激素在脓毒症中应用的研究进展[J] 岳超;赵允召; 医学研究生学报 2013, 08

High-mobility group box 1 (HMGB1) in childhood: from bench to bedside[J] Valeria Chirico;Antonio Lacquaniti;Vincenzo Salpietro;Caterina Munafò;Maria Pia Calabrò;Michele Buemi;Teresa Arrigo;Carmelo Salpietro European Journal of Pediatrics 2014,

Receptor for Advanced Glycation End Products and Its Involvement in Inflammatory Diseases[J] Yaw Kuang Chuah;Rusliza Basir;Herni Talib;Tung Hing Tie;Norshariza Nordin;Madhav Bhatia International Journal of Inflammation 2013,

Soluble receptor for advanced glycation end products predicts 28-day mortality in critically ill patients with sepsis[J] Helena Brodska;Karin Malickova;Jiri Valenta;Anthony Fabio;Tomas Drabek Scandinavian Journal of Clinical & Laboratory Inv 2013,

Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock; 2012[J] R. P. Dellinger;Mitchell M. Levy;Andrew Rhodes;Djillali Annane;Herwig Gerlach;Steven M. Opal;Jonathan E. Sevransky;Charles L. Sprung;Ivor S. Douglas;Roman Jaeschke;Tiffany M. Osborn;Mark E. Nunnally;Sean R. Townsend;Konrad Reinhart;Ruth M. Kleinpell;Derek C. Angus;Clifford S. Deutschman;Flavia R. Machado;Gordon D. Rubenfeld;Steven Webb;Richard J. Beale;Jean-Louis Vincent;Rui Moreno Inten

The effect of sRAGE-Fc fusion protein attenuates inflammation and decreases mortality in a murine cecal ligation and puncture model[J] Su Jin Jeong;Beom Jin Lim;Sungha Park;Donghoon Choi;Hye Won Kim;Nam Su Ku;Sang Hoon Han;Chang Oh Kim;Jun Yong Choi;Young Goo Song;June Myung Kim Inflammation Research 2012,

Ligands of the receptor for advanced glycation end products; including high-mobility group box 1; limit bacterial dissemination during Escherichia coli peritonitis[J] Marieke A. D. van Zoelen;Ahmed Achouiti;Ann-Marie Schmidt;Huan Yang;Sandrine Florquin;Kevin J. Tracey;Tom van der Poll Critical Care Medicine 2010,

High‐mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity[J] Marco E.Bianchi;Angelo A.Manfredi Immunological Reviews 2007,

S100A8 and S100A9 in inflammation and cancer[J] Christoffer Gebhardt;Julia Németh;Peter Angel;Jochen Hess Biochemical Pharmacology 2006,